us-abfm MCQ (SBA): Diabetes Pharmacotherapy

Instant feedback + full explanation. One question, done properly.

EasyEndocrinologyDiabetes Pharmacotherapyus-abfm

A 35-year-old with class II obesity and T2D (A1C 7.6%) without ASCVD seeks pharmacotherapy for weight and glycaemia. Which class offers both weight loss and glycaemic benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Diabetes Pharmacotherapy — Answer & Explanation | iatroX